The article explores the growth of diabetes stocks, with a focus on Tandem Diabetes Care, Inc. (NASDAQ:TNDM). The market for diabetes care products is expanding rapidly, particularly for continuous glucose monitoring devices, with a projected revenue increase to $33.4 billion by 2030.